Related Experiment Video
Updated: May 16, 2026
10:14
Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
Published on: May 26, 2023
Submacular hemorrhage: a study amongst Indian eyes
Ekta Rishi1, Lingam Gopal, Pukhraj Rishi
1Shri Bhagwan Mahavir Vitreoretinal Services, Sankara Nethralaya, Chennai, Tamil Nadu, India.
Indian Journal of Ophthalmology
|December 4, 2012
Summary
Early intervention for submacular hemorrhage (SMH) improves anatomical outcomes. Recombinant tissue plasminogen activator (r-tPA) assisted vitrectomy and pneumatic displacement are effective SMH management options.
Area of Science:
- Ophthalmology
- Retinal Diseases
- Surgical Outcomes
Background:
- Submacular hemorrhage (SMH) is a significant cause of vision loss.
- Effective management strategies are crucial for preserving visual function.
Purpose of the Study:
- To compare management outcomes of different treatment modalities for SMH in Indian patients.
- To identify factors influencing treatment success in SMH.
Main Methods:
- Retrospective study of patients with SMH (1999-2006).
- Compared three treatment groups: vitrectomy with subretinal r-tPA, pneumatic displacement with intravitreal r-tPA and gas, and pneumatic displacement with intraocular gas.
- Assessed anatomical (foveal displacement) and functional (visual acuity gain) outcomes.
Main Results:
- No significant difference in anatomical or functional outcomes between treatment groups.
- Shorter duration of SMH (<7.5 days) correlated with better anatomical outcomes.
- SMH size did not impact anatomical or functional results.
Conclusions:
- Early treatment of SMH is associated with improved anatomical outcomes.
- Pneumatic displacement with r-tPA and r-tPA assisted vitrectomy are favorable SMH management options.
- Posterior segment conditions and SMH duration may influence treatment choice and outcomes.
